Dairy products and health: Focus on their constituents or on the matrix?

International Dairy Journal

Volumn 18, Issue 5, 2008, Pages 425-435

  Steijns, Jan M ^a  

^a FRIESLANDCAMPINA   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR SYSTEM; DISEASES; FATTY ACIDS; NUTRITION; OILS AND FATS; PROTEINS;

CARDIOVASCULAR DISEASES; DIETARY RECOMMENDATIONS; SATURATED FATTY ACIDS;

DAIRY PRODUCTS;

EID: 40849112978     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2007.11.008     Document Type: Review

References (78)

1. Alonso A., Beunza J.J., Delgado-Rodríguez M., Alfredo Martínez J., and Martínez-González M.A. Low-fat dairy consumption and reduced risk of hypertension: The Seguimiento Universidad de Navarra (SUN) cohort. American Journal of Clinical Nutrition 82 (2005) 972-979
2. Artaud-Wild S.M., Connor S.L., Sexton G., and Connor W.E. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. Circulation 88 (1993) 2771-2779
3. Berkner K.L. The vitamin K-dependent carboxylase. Annual Review of Nutrition 25 (2005) 127-149
4. Berneis K.K., and Krauss R.M. Metabolic origins and clinical significance of LDL heterogeneity. Journal of Lipid Research 43 (2002) 1363-1379
5. Bonjour J.-P. Dietary protein: An essential nutrient for bone health. Journal of the American College of Nutrition 24 (2005) 526S-536S
6. Buchner, F. L., Hoekstra, J., van den Berg, S. W., Wieleman, F., & van Rossum, C. T. M. (2007). Kwantificeren van de gezondheidseffecten van voeding (Quantifying health effects of nutrition). RIVM report, 350080001. The Netherlands National Institute for Public Health and the Environment.
7. Chardigny J.M., Malpuech-Brugere C., Dionisi F., Bauman D.E., German B., Mensink R.P., et al. Rationale and design of the TRANSFACT project phase I: A study to assess the effect of the two different dietary sources of trans fatty acids on cardiovascular risk factors in humans. Contemporary Clinical Trials 27 (2006) 364-373
8. Craddick S.R., Elmer P.J., Obarzanek E., Vollmer W.M., Svetky L.P., and Swain M.C. The DASH diet and blood pressure. Current Atherosclerosis Reports 5 (2003) 491-494
9. Craig-Schmidt M.C. World-wide consumption of trans fatty acids. Atherosclerosis Supplements 7 (2006) 1-4
10. De Greyt W., Radany O., Kellens M., and Huyghebaert A. Contribution of trans-fatty acids from vegetable oils and margarines to the Belgian diet. Fat/Lipid 1 (1996) 30-33
11. Drewnowski A. Concept of a nutritious food: Towards a nutrient density score. American Journal of Clinical Nutrition 82 (2005) 721-732
12. Dutch Nutrition Center. (1998). Zo eet Nederland. Resultaten van de voedselconsumptiepeiling 1997-1998. Dutch Food Consumption Survey of 1997-1998. ISBN: 90 5177 036 7.
13. EFSA Report. Opinion of the scientific panel on dietetic products, nutrition and allergies on a request from the Commission related to the presence of trans fatty acids in foods and the effect on human health of the consumption of trans fatty acids. The EFSA Journal 81 (2004) 1-49
14. Elwood P.C., Pickering J.E., Fehily A.M., Hughes J., and Ness A.R. Milk drinking, ischaemic heart disease and ischaemic stroke. I. Evidence from the Caerphilly cohort. European Journal of Clinical Nutrition 58 (2004) 711-717
15. Elwood P.C., Pickering J.E., Hughes J., Fehily A.M., and Ness A.R. Milk drinking, ischaemic heart disease and ischaemic stroke. II. Evidence from cohort studies. European Journal of Clinical Nutrition 58 (2004) 718-724
16. Geleijnse J.M., Grobbee D.E., and Kok F.J. Impact of dietary and lifestyle factors on the prevalence of hypertension in Western populations. Journal of Human Hypertension 19 (2005) S1-S4
17. Geleijnse J.M., Vermeer C., Grobbee D.E., Schurgers L.J., Knapen M.H.J., van der Meer I.M., et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The Rotterdam study. Journal of Nutrition 134 (2004) 3100-3105
18. German J.B., and Dillard C.J. Saturated fats: What dietary intake?. American Journal of Clinical Nutrition 80 (2004) 550-559
19. Hulshof K.F.A.M., van Erp-Baart M.A., Anttolainen M., Becker W., Church S.M., Couet C., et al. Intake of fatty acids in Western Europe with emphasis on trans fatty acids: The TRANSFAIR study. European Journal of Clinical Nutrition 53 (1999) 143-157
20. Hunter E.J. Dietary trans fatty acids: Review of recent human studies and food industry responses. Lipids 41 (2006) 967-992
21. Huth P.J. Do ruminant trans fatty acids impact coronary heart disease risk?. Lipid Technology 19 (2007) 59-62
22. Huth P.J., DiRienzo D.B., and Miller G.D. Major scientific advances with dairy foods in nutrition and health. Journal of Dairy Science 89 (2006) 1207-1221
23. Jakobsen M.U., Bysted A., Andersen N.L., Heitmann B.L., Hartkopp H.B., Leth T., et al. Intake of ruminant trans fatty acids in the Danish population aged 1-80 years. European Journal of Clinical Nutrition 60 (2006) 312-318
24. Jensen R.G. The composition of bovine milk lipids: January 1995 to December 2000. Journal of Dairy Science 85 (2002) 295-350
25. Joint FAO/WHO Expert Consultation. (2003). Diet, nutrition and the prevention of chronic diseases. WHO technical report series 916 (pp. 3-108). Geneva, Switzerland: World Health Organization.
26. Karppanen H., Karppanen P., and Mervalla E. Why and how to implement sodium, potassium, calcium, and magnesium changes in food items and diets?. Journal of Human Hypertension 19 (2005) S10-S19
27. Kießling G., Schneider J., and Jahreis G. Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. European Journal of Clinical Nutrition 56 (2002) 843-849
28. Krauss R.M. Dietary and genetic probes of atherogenic dyslipidemia. Arteriosclerosis, Thrombosis, and Vascular Biology 25 (2005) 2265-2272
29. Krauss R.M., Blanche P.J., Rawlings R.S., Fernstrom H.S., and Williams P.T. Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. American Journal of Clinical Nutrition 83 (2006) 1025-1031
30. Kühlsen N., Pfeuffer M., Soustre Y., MacGibbon A., Lindmark-Mansson H., and Schrezenmeir J. Trans fatty acids: Scientific progress and labelling. Bulletin of the International Dairy Federation 393 (2005) 1-19
31. Layman D.K. Protein quantity and quality at levels above the RDA improves adult weight loss. Journal of the American College of Nutrition 23 (2004) 631S-636S
32. Lock A.L., Parodi P.W., and Bauman D.E. The biology of trans fatty acids: Implications for human health and the dairy industry. Australian Journal of Dairy Technology 60 (2005) 134-142
33. López-Fandiňo R., Otte J., and van Camp J. Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity. International Dairy Journal 16 (2006) 1277-1293
34. Marten B., Pfeuffer M., and Schrezenmeir J. Medium-chain triglycerides. International Dairy Journal 16 (2006) 1374-1382
35. McCarron D.A., and Heaney R.P. Estimated healthcare savings associated with adequate dairy food intake. American Journal of Hypertension 17 (2004) 88-97
36. Mensink R.P. Effects of stearic acid on plasma lipid and lipoproteins in humans. Lipids 40 (2005) 1201-1205
37. Mensink R.P., Zock P.L., Kester A.D.M., and Katan M.B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials. American Journal of Clinical Nutrition 77 (2003) 1146-1155
38. Michaelidou A., and Steijns J. Nutritional and technological aspects of minor bioactive components in milk and whey: Growth factors, vitamins and nucleotides. International Dairy Journal 16 (2006) 1421-1426
39. Miller G.D., DiRienzo D.D., Reusser M.E., and McCarron D.A. Benefits of dairy product consumption on blood pressure in humans: A summary of the biomedical literature. Journal of the American College of Nutrition 19 (2000) 147S-164S
40. Miller, G. D., Jarvis, J. K., & McBean, L. D. (2007). Contribution of dairy foods to health throughout the life cycle. In Handbook of dairy foods and nutrition (3rd ed.) (pp. 339-399). Boca Raton, FL, USA: CRC Press.
41. Moore L.L., Singer M.R., Bradlee M.L., Djoussé L., Proctor M.H., Cupples L.A., et al. Intake of fruits, vegetables, and dairy products in early childhood and subsequent blood pressure change. Epidemiology 16 (2005) 4-11
42. Moss M., and Freed D. The cow and the coronary: Epidemiology, biochemistry and immunology. International Journal of Cardiology 87 (2003) 203-216
43. Mozaffarian D., Katan M.B., Ascherio A., Stampfer M.J., and Willett W.C. Trans fatty acids and cardiovascular disease. New England Journal of Medicine 354 (2006) 1601-1613
44. Nestel P.J., Chronopulos A., and Cehun M. Dairy fat in cheese raises LDL cholesterol less than that in butter in mildly hypercholesterolaemic subjects. European Journal of Clinical Nutrition 59 (2005) 1059-1063
45. Nosaka N., Maki H., Suzuki Y., Haruna H., Ohara A., Kasai M., et al. Effects of margarine containing medium-chain triacylglycerols on body fat reduction in humans. Journal of Atherosclerosis and Thrombosis 10 (2003) 290-298
46. Parodi P.W. Milk fat in human nutrition. Australian Journal of Dairy Technology 59 (2004) 3-59
47. Pfeuffer M., and Schrezenmeier J. Milk and the metabolic syndrome. Obesity Reviews 8 (2006) 109-118
48. Precht D., and Molkentin J. Trans fatty acids: implications for health, analytical methods, incidence in edible fats and intake. Die Nahrung 39 (1995) 343-374
49. Ruidavets J.-B., Bogard V., Simon C., Dallongeville J., Ducimetière P., Arveiler D., et al. Independent contribution of dairy products and calcium intake to blood pressure variations at a population level. Journal of Hypertension 24 (2006) 671-681
50. Sacks F.M. The apolipoprotein story. Atherosclerosis Supplements 7 (2006) 23-27
51. Sacks F.M., and Katan M. Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. The American Journal of Medicine 113 (2002) 13S-24S
52. Schaafsma G. Health issues of whey proteins: 2. Weight management. Current Topics in Nutraceutical Research 4 (2006) 123-126
53. Schaafsma G. Health issues of whey proteins: 1. Protection of lean body mass. Current Topics in Nutraceutical Research 4 (2006) 113-122
54. Schaafsma G., and Steijns J.M. Dairy ingredients as a source of functional foods. In: Schmiddle M.K., and Labuza T.P. (Eds). Essentials of functional foods (2000), Aspen Publishers Inc., Gaithersburg, MD, USA 181-204
55. Schurgers L.J., and Vermeer C. Determination of phylloquinone and menaquinone in food. Effect of the food matrix on circulating vitamin K concentrations. Haemostasis 30 (2000) 298-307
56. Sjogren P., Rosell M., Skoglund-Andersson C., Zdravkovic S., Vessby B., de Faire U., et al. Milk-derived fatty acids are associated with a more favorable LDL particle size distribution in healthy men. Journal of Nutrition 134 (2004) 1729-1735
57. Snijder M.B., van der Heijden A.A., van Dam R.M., Stehouwer C.D., Hiddink G.J., Nijpels G., et al. Is higher dairy consumption associated with lower body weight and fewer metabolic disturbances? The Hoorn Study. American Journal of Clinical Nutrition 85 (2007) 989-995
58. Steijns J.M. Milk ingredients as nutraceuticals. International Journal of Dairy Technology 54 (2001) 81-88
59. Steijns J.M. Proteins, peptides and amino acids. In: Young J. (Ed). Guide to functional food ingredients (2001), Leatherhead Food RA Publishing, Surrey, UK 235-275
60. Steijns J.M. Dairy derived health promoting ingredients. The International Review of Food Science and Technology 2 (2003) 76-78
61. Steijns J.M., and van Hooydonk A.C.M. Occurrence, structure, biochemical properties and technological characteristics of lactoferrin. British Journal of Nutrition 84 Suppl. 1 (2000) S11-S17
62. Stender, S., & Dyerberg, J. (2003). The influence of trans fatty acids on health. A report of the Danish Nutrition Council. Publication no. 34 (4th ed.), Copenhagen, Denmark.
63. St-Onge M.-P., Farnworth E.R., and Jones P.J.H. Consumption of fermented and nonfermented dairy products: Effects on cholesterol concentrations and metabolism. American Journal of Clinical Nutrition 71 (2000) 674-681
64. Temme E.H., Mensink R.P., and Hornstra G. Effects of medium chain fatty acids (MCFA), myristic acid, and oleic acid on serum lipoproteins in healthy subjects. Journal of Lipid Research 38 (1996) 1746-1754
65. Temme E.H., Mensink R.P., and Hornstra G. Comparison of the effects of diets enriched in lauric acid, palmitic, or oleic acids on serum lipids and lipoproteins in healthy women and men. American Journal of Clinical Nutrition 63 (1997) 897-903
66. Tholstrup T. Dairy products and cardiovascular disease. Current Opinion in Lipidology 17 (2006) 1-10
67. Tholstrup T., Høy C.-E., Normann Andersen L., Christensen R.D.K., and Sandström B. Does fat in milk, butter and cheese affect blood lipids and cholesterol differently?. Journal of the American College of Nutrition 23 (2004) 169-176
68. Tholstrup T., Raff M., Basu S., Nonboe P., Sejrsen K., and Straarup E.M. Effects of butter high in ruminant trans and monounsaturated fatty acids on lipoproteins, incorporation of fatty acids into lipid classes, plasma C-reactive protein, oxidative stress, hemostatic variables, and insulin in healthy young men. American Journal of Clinical Nutrition 83 (2006) 237-243
69. Thijssen, M. (2006). Dietary C18 fatty acids: Effects on cardiovascular risk markers and fatty acid metabolism (chapter 7, pp. 126-148). PhD Thesis, The Netherlands: Maastricht University.
70. Thijssen M.A., and Mensink R.P. Small differences in the effects of stearic acid, oleic acid, and linoleic acid on the serum lipoprotein profile of humans. American Journal of Clinical Nutrition 82 (2005) 510-516
71. Townsend R.T., McFadden C.B., Ford V., and Cadée J.A. A randomized, double-blind, placebo-controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension. American Journal of Hypertension 17 (2004) 1056-1058
72. Tricon S., Burdge G.C., Jones E.L., Russell J.J., El-Khazen S., Moretti E., et al. Effects of dairy products naturally enriched with cis-9,trans-11 conjugated linoleic acid on the blood lipid profile in healthy middle-aged men. American Journal of Clinical Nutrition 83 (2006) 744-753
73. Tricon S., Burdge G.C., Williams C., Calder P., and Yaqoob P. The effects of conjugated linoleic acid on human health-related outcomes. Proceedings of the Nutrition Society 64 (2005) 171-182
74. van Kreijl, C. F., Knaap, A. G. A. C., & van Raaij, J. M. A. (2006). Our food, our health. Healthy diet and safe food in the Netherlands. RIVM Report, 270555009.
75. Vermeer C., Shearer M.J., Zittermann A., Bolton-Smith C., Szulc P., Hodges S., et al. Beyond deficiency: Potential benefits of increased intakes of vitamin K for bone and vascular health. European Journal of Nutrition 43 (2004) 325-335
76. Westerterp-Plantenga M.S., Luscombe-Marsh N., Lejeune M.P.G.M., Diepvens K., Nieuwenhuizen A., Engelen M.P.K.J., et al. Dietary protein, metabolism, and body-weight regulation: Dose-response effects. International Journal of Obesity 30 (2006) S16-S23
77. Wolk A., Furuheim M., and Vessby B. Fatty acid composition of adipose tissue and serum lipids are valid biological markers of dairy fat intake in men. Journal of Nutrition 131 (2001) 828-833
78. Wolk A., Vessby B., Ljung H., and Barrefors P. Evaluation of a biological marker of dairy fat intake. American Journal of Clinical Nutrition 68 (1998) 291-295